NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

膽固醇檢驗的全球市場:至2025年的預測與市場機會

Global Cholesterol Testing Market By Indication, By Product, By End-Product, By Test, By Age, By End-User, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934745
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

膽固醇檢驗的全球市場:至2025年的預測與市場機會 Global Cholesterol Testing Market By Indication, By Product, By End-Product, By Test, By Age, By End-User, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 111 Pages
簡介

全球膽固醇檢驗市場,由於心血管疾病及肥胖的風險增加,高齡化人口的增加,預防醫療保健的認識和採用的高漲等理由,在預測期間內預計以迅速的速度成長。

本報告提供全球膽固醇檢驗市場各市場區隔和各地區調查,市場規模及市場佔有率的預測,推動因素與課題,市場趨勢,競爭情形,企業簡介等資訊。

由於

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19對全球膽固醇檢驗市場的影響

第4章 摘要整理

第5章 客戶的迴響

第6章 全球膽固醇檢驗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各症狀(動脈粥狀硬化,糖尿病,肥胖,其他)
    • 各產品(試驗帶,試驗套件(無儀表,附儀表,郵寄))
    • 各最終產物(總膽固醇,高密度脂蛋白(HDL)膽固醇,低密度脂蛋白(LDL)膽固醇,三酸甘油酯)
    • 各檢查(脂質面板試驗/完全的脂質簡介,載脂蛋白B試驗,載脂蛋白A-1試驗,Apoe基因型鑑定試驗,載脂蛋白CII,其他)
    • 各年齡(青春期前,青春期,成人期前)
    • 各終端用戶(醫院&診所,居家醫療,其他)
    • 各公司(2019年)
    • 各地區
  • 市場魅力指數

第7章 亞太地區的膽固醇檢驗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各症狀
    • 各產品
    • 各最終產物
    • 各類型
    • 各年齡
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 新加坡
    • 澳洲

第8章 歐洲的膽固醇檢驗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各症狀
    • 各產品
    • 各最終產物
    • 各類型
    • 各年齡
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 俄羅斯
    • 西班牙

第9章 北美的膽固醇檢驗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各症狀
    • 各產品
    • 各最終產物
    • 各類型
    • 各年齡
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 北美:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第10章 南美的膽固醇檢驗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各症狀
    • 各產品
    • 各最終產物
    • 各類型
    • 各年齡
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 南美:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章 中東、非洲的膽固醇檢驗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各症狀
    • 各產品
    • 各最終產物
    • 各類型
    • 各年齡
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 中東、非洲:國家分析
    • 南非
    • 沙烏地阿拉伯
    • UAE

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與發展

第14章 競爭情形

  • 競爭的展望
  • 側寫的參與者(主要企業)
    • Abaxis, Inc.
    • Abbott Laboratories
    • Akers Biosciences, Inc.
    • Beckman Coulter, Inc.
    • Bio-Reference Laboratories
    • Boston Heart Diagnostics Corporation
    • Cell Biolabs, Inc
    • Clinical Reference Laboratory, Inc.
    • F. Hoffmann-La Roche Ltd
    • Prima Lab SA
    • PTS Diagnostics
    • Quest Diagnostics
    • Randox Laboratories
    • Sekisui Diagnostics, LLC
    • Siemens Healthineers
    • Sigma-Aldrich Corporation
    • Spectra Laboratories
    • SpectraCell Laboratories, Inc
    • Thermo Fisher Scientific
    • Unilabs

第15章 策略性推薦事項

第16章 免責聲明

目錄
Product Code: 4663

Global cholesterol testing market is expected to grow at brisk rate during the forecast period owing reasons like surge in risk of cardiovascular diseases & obesity, surge in aging population and rising awareness and adoption of preventive healthcare. Additionally, increase in healthcare expenditure by various governments around the world is also driving the cholesterol testing market. Furthermore, rapid technological advancements in cholesterol testing and growing focus on developing new products are the key factors contributing to the constant growth of technological advancements in cholesterol testing market globally.

A complete cholesterol test is also called a lipid panel or lipid profile. The test can be used to measure the amount of "good" and "bad" cholesterol and triglycerides, a type of fat, in a person's blood. Too much LDL cholesterol in blood may put the person at risk for heart disease and other serious conditions. High LDL levels can cause the build-up of plaque, a fatty substance that narrows the arteries and blocks blood from flowing normally. Additionally, growing health concerns among the population is creating huge demand for cholesterol testing. Moreover, government is also trying to improve the quality of testing and thus, the cholesterol testing market is anticipated to hold a huge growth potential for the market players in the coming years.

The global cholesterol testing market is segmented based indication, product, end product, test, age, end-user and region. Based on end-user, the market is segment between hospitals & clinics, homecare and others. In 2019, hospitals & clinics segment held the largest market share owing to increasing number of patients performed in hospitals and rising number of hospitals and clinics around the world with advanced laboratory infrastructure.

Major players operating in the global cholesterol testing market include Abaxis, Inc., Abbott Laboratories, Akers Biosciences, Inc., Beckman Coulter, Inc., Bio-Reference Laboratories, Boston Heart Diagnostics Corporation, Cell Biolabs, Inc, Clinical Reference Laboratory, Inc., F. Hoffmann-La Roche Ltd, Prima Lab SA, PTS Diagnostics, Quest Diagnostics, Randox Laboratories, Sekisui Diagnostics, LLC, Siemens Healthineers, Sigma-Aldrich Corporation, Spectra Laboratories, SpectraCell Laboratories, Inc, Thermo Fisher Scientific, Unilabs and others. The market players are focusing on various strategic initiatives like regional expansion, new product development and strategic collaborations and partnerships.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global cholesterol testing market.
  • To classify and forecast global cholesterol testing market based on indication, product, end product, test, age, end-user, company and regional distribution.
  • To identify drivers and challenges for global cholesterol testing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global cholesterol testing market.
  • To conduct pricing analysis for global cholesterol testing market.
  • To identify and analyze the profile of leading players operating in global cholesterol testing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the globe.

TechSci Research calculated the market size of global cholesterol testing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Cholesterol testing companies, hospitals/clinics and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to cholesterol testing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global cholesterol testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Indication:

Atherosclerosis

Diabetes

Obesity

Others

  • Market, By Product:

Test Strips

Test Kits

Without meter

With meter

Mail-in

  • Market, By End-Product:

Total cholesterol

High-density lipoprotein (HDL) cholesterol

Low-density lipoprotein (LDL) cholesterol

Triglycerides

  • Market, By Test:

Lipid Panel Test/Complete Lipid Profile

Apolipoprotein B Test

Apolipoprotein A-1 Test

Apoe Genotyping Test

Apolipoprotein CII

Others

  • Market, By Age:

Before Puberty

Puberty

Adulthood

  • Market, By End-User:

Hospitals & Clinics

Homecare

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global cholesterol testing market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Cholesterol Testing Market

4. Executive Summary

5. Voice of Customer

6. Global Cholesterol Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication (Atherosclerosis, Diabetes, Obesity, Others)
    • 6.2.2. By Product (Test Strips, Test Kits (Without meter, With meter, Mail-in))
    • 6.2.3. By End-Product (Total cholesterol, High-density lipoprotein (HDL) cholesterol, Low-density lipoprotein (LDL) cholesterol, Triglycerides)
    • 6.2.4. By Test (Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B Test, Apolipoprotein A-1 Test, Apoe Genotyping Test, Apolipoprotein CII, Others)
    • 6.2.5. By Age (Before Puberty, Puberty, Adulthood)
    • 6.2.6. By End-User (Hospitals & Clinics, Homecare, Others)
    • 6.2.7. By Company (2019)
    • 6.2.8. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Cholesterol Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Product
    • 7.2.3. By End-Product
    • 7.2.4. By Type
    • 7.2.5. By Age
    • 7.2.6. By End-User
    • 7.2.7. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Asia-Pacific: Country Analysis
    • 7.4.1. China Cholesterol Testing Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Indication
        • 7.4.1.2.2. By Product
        • 7.4.1.2.3. By End-Product
        • 7.4.1.2.4. By Type
        • 7.4.1.2.5. By Age
        • 7.4.1.2.6. By End-User
    • 7.4.2. India Cholesterol Testing Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Indication
        • 7.4.2.2.2. By Product
        • 7.4.2.2.3. By End-Product
        • 7.4.2.2.4. By Type
        • 7.4.2.2.5. By Age
        • 7.4.2.2.6. By End-User
    • 7.4.3. Japan Cholesterol Testing Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Indication
        • 7.4.3.2.2. By Product
        • 7.4.3.2.3. By End-Product
        • 7.4.3.2.4. By Type
        • 7.4.3.2.5. By Age
        • 7.4.3.2.6. By End-User
    • 7.4.4. South Korea Cholesterol Testing Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Indication
        • 7.4.4.2.2. By Product
        • 7.4.4.2.3. By End-Product
        • 7.4.4.2.4. By Type
        • 7.4.4.2.5. By Age
        • 7.4.4.2.6. By End-User
    • 7.4.5. Singapore Cholesterol Testing Market Outlook
      • 7.4.5.1. Market Size & Forecast
        • 7.4.5.1.1. By Value
      • 7.4.5.2. Market Share & Forecast
        • 7.4.5.2.1. By Indication
        • 7.4.5.2.2. By Product
        • 7.4.5.2.3. By End-Product
        • 7.4.5.2.4. By Type
        • 7.4.5.2.5. By Age
        • 7.4.5.2.6. By End-User
    • 7.4.6. Australia Cholesterol Testing Market Outlook
      • 7.4.6.1. Market Size & Forecast
        • 7.4.6.1.1. By Value
      • 7.4.6.2. Market Share & Forecast
        • 7.4.6.2.1. By Indication
        • 7.4.6.2.2. By Product
        • 7.4.6.2.3. By End-Product
        • 7.4.6.2.4. By Type
        • 7.4.6.2.5. By Age
        • 7.4.6.2.6. By End-User

8. Europe Cholesterol Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Product
    • 8.2.3. By End-Product
    • 8.2.4. By Type
    • 8.2.5. By Age
    • 8.2.6. By End-User
    • 8.2.7. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. Europe: Country Analysis
    • 8.4.1. France Cholesterol Testing Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Indication
        • 8.4.1.2.2. By Product
        • 8.4.1.2.3. By End-Product
        • 8.4.1.2.4. By Type
        • 8.4.1.2.5. By Age
        • 8.4.1.2.6. By End-User
    • 8.4.2. Germany Cholesterol Testing Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Indication
        • 8.4.2.2.2. By Product
        • 8.4.2.2.3. By End-Product
        • 8.4.2.2.4. By Type
        • 8.4.2.2.5. By Age
        • 8.4.2.2.6. By End-User
    • 8.4.3. United Kingdom Cholesterol Testing Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Indication
        • 8.4.3.2.2. By Product
        • 8.4.3.2.3. By End-Product
        • 8.4.3.2.4. By Type
        • 8.4.3.2.5. By Age
        • 8.4.3.2.6. By End-User
    • 8.4.4. Italy Cholesterol Testing Market Outlook
      • 8.4.4.1. Market Size & Forecast
        • 8.4.4.1.1. By Value
      • 8.4.4.2. Market Share & Forecast
        • 8.4.4.2.1. By Indication
        • 8.4.4.2.2. By Product
        • 8.4.4.2.3. By End-Product
        • 8.4.4.2.4. By Type
        • 8.4.4.2.5. By Age
        • 8.4.4.2.6. By End-User
    • 8.4.5. Russia Cholesterol Testing Market Outlook
      • 8.4.5.1. Market Size & Forecast
        • 8.4.5.1.1. By Value
      • 8.4.5.2. Market Share & Forecast
        • 8.4.5.2.1. By Indication
        • 8.4.5.2.2. By Product
        • 8.4.5.2.3. By End-Product
        • 8.4.5.2.4. By Type
        • 8.4.5.2.5. By Age
        • 8.4.5.2.6. By End-User
    • 8.4.6. Spain Cholesterol Testing Market Outlook
      • 8.4.6.1. Market Size & Forecast
        • 8.4.6.1.1. By Value
      • 8.4.6.2. Market Share & Forecast
        • 8.4.6.2.1. By Indication
        • 8.4.6.2.2. By Product
        • 8.4.6.2.3. By End-Product
        • 8.4.6.2.4. By Type
        • 8.4.6.2.5. By Age
        • 8.4.6.2.6. By End-User

9. North America Cholesterol Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Product
    • 9.2.3. By End-Product
    • 9.2.4. By Type
    • 9.2.5. By Age
    • 9.2.6. By End-User
    • 9.2.7. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. North America: Country Analysis
    • 9.4.1. United States Cholesterol Testing Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Indication
        • 9.4.1.2.2. By Product
        • 9.4.1.2.3. By End-Product
        • 9.4.1.2.4. By Type
        • 9.4.1.2.5. By Age
        • 9.4.1.2.6. By End-User
    • 9.4.2. Mexico Cholesterol Testing Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Indication
        • 9.4.2.2.2. By Product
        • 9.4.2.2.3. By End-Product
        • 9.4.2.2.4. By Type
        • 9.4.2.2.5. By Age
        • 9.4.2.2.6. By End-User
    • 9.4.3. Canada Cholesterol Testing Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Indication
        • 9.4.3.2.2. By Product
        • 9.4.3.2.3. By End-Product
        • 9.4.3.2.4. By Type
        • 9.4.3.2.5. By Age
        • 9.4.3.2.6. By End-User

10. South America Cholesterol Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Product
    • 10.2.3. By End-Product
    • 10.2.4. By Type
    • 10.2.5. By Age
    • 10.2.6. By End-User
    • 10.2.7. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. South America: Country Analysis
    • 10.4.1. Brazil Cholesterol Testing Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Indication
        • 10.4.1.2.2. By Product
        • 10.4.1.2.3. By End-Product
        • 10.4.1.2.4. By Type
        • 10.4.1.2.5. By Age
        • 10.4.1.2.6. By End-User
    • 10.4.2. Argentina Cholesterol Testing Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Indication
        • 10.4.2.2.2. By Product
        • 10.4.2.2.3. By End-Product
        • 10.4.2.2.4. By Type
        • 10.4.2.2.5. By Age
        • 10.4.2.2.6. By End-User
    • 10.4.3. Colombia Cholesterol Testing Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Indication
        • 10.4.3.2.2. By Product
        • 10.4.3.2.3. By End-Product
        • 10.4.3.2.4. By Type
        • 10.4.3.2.5. By Age
        • 10.4.3.2.6. By End-User

11. Middle East and Africa Cholesterol Testing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Indication
    • 11.2.2. By Product
    • 11.2.3. By End-Product
    • 11.2.4. By Type
    • 11.2.5. By Age
    • 11.2.6. By End-User
    • 11.2.7. By Country
  • 11.3. Market Attractiveness Index
  • 11.4. MEA: Country Analysis
    • 11.4.1. South Africa Cholesterol Testing Market Outlook
      • 11.4.1.1. Market Size & Forecast
        • 11.4.1.1.1. By Value
      • 11.4.1.2. Market Share & Forecast
        • 11.4.1.2.1. By Indication
        • 11.4.1.2.2. By Product
        • 11.4.1.2.3. By End-Product
        • 11.4.1.2.4. By Type
        • 11.4.1.2.5. By Age
        • 11.4.1.2.6. By End-User
    • 11.4.2. Saudi Arabia Cholesterol Testing Market Outlook
      • 11.4.2.1. Market Size & Forecast
        • 11.4.2.1.1. By Value
      • 11.4.2.2. Market Share & Forecast
        • 11.4.2.2.1. By Indication
        • 11.4.2.2.2. By Product
        • 11.4.2.2.3. By End-Product
        • 11.4.2.2.4. By Type
        • 11.4.2.2.5. By Age
        • 11.4.2.2.6. By End-User
    • 11.4.3. UAE Cholesterol Testing Market Outlook
      • 11.4.3.1. Market Size & Forecast
        • 11.4.3.1.1. By Value
      • 11.4.3.2. Market Share & Forecast
        • 11.4.3.2.1. By Indication
        • 11.4.3.2.2. By Product
        • 11.4.3.2.3. By End-Product
        • 11.4.3.2.4. By Type
        • 11.4.3.2.5. By Age
        • 11.4.3.2.6. By End-User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Abaxis, Inc.
    • 14.2.2. Abbott Laboratories
    • 14.2.3. Akers Biosciences, Inc.
    • 14.2.4. Beckman Coulter, Inc.
    • 14.2.5. Bio-Reference Laboratories
    • 14.2.6. Boston Heart Diagnostics Corporation
    • 14.2.7. Cell Biolabs, Inc
    • 14.2.8. Clinical Reference Laboratory, Inc.
    • 14.2.9. F. Hoffmann-La Roche Ltd
    • 14.2.10. Prima Lab SA
    • 14.2.11. PTS Diagnostics
    • 14.2.12. Quest Diagnostics
    • 14.2.13. Randox Laboratories
    • 14.2.14. Sekisui Diagnostics, LLC
    • 14.2.15. Siemens Healthineers
    • 14.2.16. Sigma-Aldrich Corporation
    • 14.2.17. Spectra Laboratories
    • 14.2.18. SpectraCell Laboratories, Inc
    • 14.2.19. Thermo Fisher Scientific
    • 14.2.20. Unilabs

15. Strategic Recommendations

16. About Us & Disclaimer